Balyasny Asset Management LLC Ampio Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $5,196 - $15,265	32,480 New	32,480 $5,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $73,328 - $109,083	-60,602 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $30,764 - $39,047	19,721 Added 48.24%	60,602 $101,000
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $55,598 - $101,793	40,881 New	40,881 $69,000
Q2 2018 Aug 14, 2018	SELL	$1.66 - $3.82 $75,032 - $172,664	-45,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.16 - $3.48 $97,632 - $157,296	45,200 New	45,200 $154,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.